Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay

Journal of Clinical Microbiology

Volumn 46, Issue 12, 2008, Pages 4004-4010

  Pang, Xiaoli ^a,b,c   Humar, Atul ^b   Preiksaitis, Jutta K ^a,b  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS; FLUORESCENCE ANALYSIS; GENOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIREMIA;

BASE SEQUENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA PRIMERS; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

CYTOMEGALOVIRUS;

EID: 57349114052     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01341-08     Document Type: Article

References (42)

1. Boeckh, M., R. A. Bowden, J. M. Goodrich, M. Pettinger, and J. D. Meyers. 1992. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 80:1358-1364.
2. Chandler, S. H., H. H. Handsfield, and J. K. McDougall. 1987. Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease. J. Infect. Dis. 155:655-660.
3. Chou, S. W., and K. M. Dennison. 1991. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J. Infect. Dis. 163:1229-1234.
4. Coaquette, A., A. Bourgeois, C. Dirand, A. Varin, W. Chen, and G. Herbein. 2004. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin. Infect. Dis. 39:155-161.
5. Cranage, M. P., T. Kouzarides, A. T. Bankier, S. Satchwell, K. Weston, P. Tomlinson, B. Barrell, H. Hart, S. E. Bell, A. C. Minson, and G. L. Smith. 1986. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J. 5:3057-3063.
6. Drew, W. L., E. S. Sweet, R. C. Miner, and E. S. Mocarski. 1984. Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J. Infect. Dis. 150:952-953.
7. Grundy, J. E., S. F. Lui, M. Super, N. J. Berry, P. Sweny, O. N. Fernando, J. Moorhead, and P. D. Griffiths. 1988. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 2:132-135.
8. Hodson, E. M., C. A. Jones, A. C. Webster, G. F. Strippoli, P. G. Barclay, K. Kable, D. Vimalachandra, and J. C. Craig. 2005. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 365:2105-2115.
9. Humar, A., D. Kumar, C. Gilbert, and G. Boivin. 2003. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J. Infect. Dis. 188:581-584.
10. Klein, M., K. Schoppel, N. Amvrossiadis, and M. Mach. 1999. Strain-specific neutralization of human cytomegalovirus isolates by human sera. J. Virol. 73:878-886.
11. Kutyavin, I. V., I. A. Afonina, A. Mills, V. V. Gorn, E. A. Lukhtanov, E. S. Belousov, M. J. Singer, D. K. Walburger, S. G. Lokhov, A. A. Gall, R. Dempcy, M. W. Reed, R. B. Meyer, and J. Hedgpeth. 2000. 3′-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 28:655-661.
12. Lantto, J., J. M. Fletcher, and M. Ohlin. 2003. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus. Virology 305:201-209.
13. Limaye, A. P., L. Corey, D. M. Koelle, C. L. Davis, and M. Boeckh. 2000. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 356:645-649.
14. Mattick, C., D. Dewin, S. Polly, E. Sevilla-Reyes, S. Pignatelli, W. Rawlinson, G. Wilkinson, P. Dal Monte, and U. A. Gompels. 2004. Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology 318:582-597.
15. Meyer-König, U., K. Ebert, B. Schrage, S. Pollak, and F. T. Hufert. 1998. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352:1280-1281.
16. Mhiri, L., J. F. Meritet, P. Lebon, and A. Slim. 2008. Different human cytomegalovirus glycoprotein B (gB) genotype distribution. Pathol. Biol. (Paris) 56:39-42.
17. Murphy, E., D. Yu, J. Grimwood, J. Schmutz, M. Dickson, M. A. Jarvis, G. Hahn, J. A. Nelson, R. M. Myers, and T. E. Shenk. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 100:14976-14981.
18. Navarro, D., P. Paz, S. Tugizov, K. Topp, J. La Vail, and L. Pereira. 1993. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197:143-158.
19. Nitsche, A., N. Steuer, C. A. Schmidt, O. Landt, and W. Siegert. 1999. Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin. Chem. 45:1932-1937.
20. Novak, Z., S. A. Ross, R. K. Patro, S. K. Pati, R. A. Kumbla, S. Brice, and S. B. Boppana. 2008. Cytomegalovirus strain diversity in seropositive women. J. Clin. Microbiol. 46:882-886.
21. Numazaki, K., M. Ikehata, and S. Chiba. 2000. Subtyping of cytomegalovirus strains obtained from immunocompetent children. In Vivo 14:745-746.
22. Pang, X. L., L. Chui, J. Fenton, B. Leblanc, and J. Preiksaitis. 2003. Comparison of LightCycler PCR, Cobas Amplicor CMV Monitor, and pp65 antigenemia assays for quantitative cytomegalovirus viral loads in peripheral blood from patients after solid organ transplantation. J. Clin. Microbiol. 41:3167-3174.
23. Paya, C. V., J. A. Wilson, M. J. Espy, I. G. Sia, M. J. DeBernardi, T. F. Smith, R. Patel, G. Jenkins, W. S. Harmsen, D. J. Vanness, and R. H. Wiesner. 2002. Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial. J. Infect. Dis. 185:854-860.
24. Picone, O., J.-M. Costa, M. Leruez-Ville, P. Ernault, M. Olivi, and Y. Ville. 2004. Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenatal Diagn. 24:1001-1006.
25. Pignatelli, S., P. Dal Monte, G. Rossini, S. Chou, T. Gojobori, K. Hanada, J. J. Guo, W. Rawlinson, W. Britt, M. Mach, and M. P. Landini. 2003. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J. Gen. Virol. 84:647-655.
26. Plotkin, S. A., S. E. Starr, H. M. Friedman, E. Gönczöl, and R. E. Weibel. 1989. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J. Infect. Dis. 159:860-865.
27. Preiksaitis, J. K., D. C. Brennan, J. Fishman, and U. Allen. 2005. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am. J. Transplant. 5:218-227.
28. Puchhammer-Stöckl, E., I. Görzer, A. Zoufaly, P. Jaksch, C. C. Bauer, W. Klepetko, and T. Popow-Kraupp. 2006. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 81:187-194.
29. Rasmussen, L., A. Geissler, and M. Winters. 2003. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J. Infect. Dis. 187:809-819.
30. Razonable, R. R., A. Rivero, A. Rodriguez, J. Wilson, J. Daniels, G. Jenkins, T. Larson, W. C. Hellinger, J. R. Spivey, and C. V. Paya. 2001. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J. Infect. Dis. 84:1461-1464.
31. Razonable, R. R., C. V. Paya, and T. F. Smith. 2002. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J. Clin. Microbiol. 40:746-752.
32. Razonable, R. R., and C. V. Paya. 2003. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 10:60-65.
33. Razonable, R. R. 2005. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Am. J. Health Syst. Pharm. 62:S7-S13.
34. Sarcinella, L., T. Mazzulli, B. Willey, and A. Humar. 2002. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J. Clin. Virol. 24:99-105.
35. Schaade, L., P. Kockelkorn, K. Ritter, and M. Kleines. 2000. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR. J. Clin. Microbiol. 38:4006-4009.
36. Smuda, C., E. Bogner, and K. Radsak. 1997. The human cytomegalovirus glycoprotein B gene (ORF UL55) is expressed early in the infectious cycle. J. Gen. Virol. 78:1981-1992.
37. Strippoli, G. F., E. M. Hodson, C. Jones, and J. C. Craig. 2006. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Transplantation 81:139-145.
38. Tarragó, D., C. Quereda, and A. Tenorio. 2003. Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR. J. Clin. Microbiol. 41:2872-2877.
39. Torok-Storb, B., M. Boeckh, C. Hoy, W. Leisenring, D. Myerson, and T. Gooley. 1997. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90:2097-2102.
40. Whiley, D. M., and T. P. Sloots. 2006. Sequence variation can affect the performance of minor groove binder TaqMan probes in viral diagnostic assays. J. Clin. Virol. 35:81-83.
41. Yun, Z., I. Lewensohn-Fuchs, P. Ljungman, and A. Vahlne. 2000. Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays. Transplantation 69:1733-1736.
42. Zweygberg Wirgart, B. Z., M. Brytting, A. Linde, B. Wahren, and L. Grillner. 1998. Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J. Clin. Microbiol. 36:3662-3669.